Video Laryngeal Mask Versus Endotracheal Tube Undergoing Laparoscopic Cholecystectomy Surgery
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jul 8, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two methods of managing the airway during laparoscopic cholecystectomy surgery, which is a procedure to remove the gallbladder. Specifically, the trial is comparing the use of a video laryngeal mask, a device that helps keep the airway open, with a traditional endotracheal tube, which is a tube inserted into the windpipe. The goal is to see which method is more effective and safer for patients undergoing this type of surgery.
To participate in this trial, you need to be at least 19 years old and scheduled for an elective laparoscopic cholecystectomy. However, certain conditions may exclude you, such as a high risk of choking, difficulties with your airway, obesity, or loose teeth. If you qualify and choose to participate, you will help researchers understand the best way to manage the airway during surgery, which could lead to better outcomes for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 19 years old
- • Patients planned for elective laparoscopic cholecystectomy
- Exclusion Criteria:
- • High risk of aspiration (e.g. gastro-esophageal reflux disease, hiatus hernia, pregnancy, history of gastrectomy)
- • Difficult airway (e.g. limitation of mouth opening, limitation of neck extension, oropharyngeal pathology)
- • Obesity (BMI \> 30 kg/m2)
- • Tooth mobility
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Hansol KIM, MD
Principal Investigator
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported